Kraig Biocraft Laboratories Announces Monster Silk(TM) Production at Quantities Necessary for Producing Textile Prototypes
August 19 2013 - 6:06AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, today
announced that the Company's pilot production program has
successfully produced a sufficient quantity of Monster Silk™
cocoons to allow the Company to make the first Monster Silk™
textile prototypes.
The cocoons still need to be reeled and processed into yarn
before the first prototype and sample textiles can be
produced. The announcement puts the Company firmly ahead of
its most recent textile production schedule. The first
textiles are slated for mechanical testing of the properties of
recombinant spider silk in various textile knits and/or weaves.
The Company also announced today a change in its production
schedule and scale of operations for its initial commercial
production program. "The timing of cocoon production from the
pilot program worked out well, because we were getting indications
from the field that the weather developing in August was not ideal
for the mulberry production needed for our commercial launch," said
Company founder and CEO, Kim K. Thompson. "We are going to
take advantage of the fact that with this supply of cocoons we have
bought ourselves some breathing room. The Company plans to
delay the launch of commercial production until sometime in
September. We can now do this with no expected impact on our
schedule to produce new textiles. By moving the production
launch to September we may also be in a position to increase the
scale of the initial commercial production by a factor of two or
more. The Laboratory is taking full advantage of the time by
working on egg production in order to increase the scale of the
commercial launch."
"The pilot production program was the first time that we raised
Monster Silk™ silkworms in real world conditions," continued
Thompson. "The success of that program has enabled us to
prepare for the creation of recombinant spider silk textiles and to
increase the scale of our pending launch of spider silk production
on a commercial scale."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024